Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research add new data to breast cancer body of knowledge
October 13th, 2005
New findings from the United States describe advances in breast cancer. Study 1: Scientists report the effect of letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen in a recent issue of Clinical Cancer Research. In a recent report, researchers in the United States conducted a study "to present the basis of the decision of the Food and Drug Administration (FDA) to grant accelerated approval for letrozole for extended adjuvant treatment of early-stage breast cancer in postmenopausal women after completion of adjuvant tamoxifen. The FDA...
Source: Women's Health Weekly (2005-10-13)
|
